Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth. - Wikidata - wikimedia - TriplyDB

Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth.

Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth.

http://www.wikidata.org/entity/Q40699776

about

Chemotherapy and chemoprevention by thiazolidinediones Clinical implication of expression of cyclooxygenase-2 and peroxisome proliferator activated-receptor gamma in epithelial ovarian tumours Pax-8-PPAR-γ fusion protein in thyroid carcinoma Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System Peroxisome proliferator-activated receptor-gamma is essential in the pathogenesis of gastric carcinoma.PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux Alternative medical treatment for radioiodine-refractory thyroid cancers.T0070907, a PPAR γ inhibitor, induced G2/M arrest enhances the effect of radiation in human cervical cancer cells through mitotic catastrophe.Association of thiazolidinediones with gastric cancer in type 2 diabetes mellitus: a population-based case-control study Standard and emerging therapies for metastatic differentiated thyroid cancer.Follicular adenoma and carcinoma of the thyroid gland.PPARγ Promotes Growth and Invasion of Thyroid Cancer Cells Genetic and biological subgroups of low-stage follicular thyroid cancer Expression of peroxisome proliferator activated receptor gamma and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma.Gene therapy for thyroid cancer.Pleiotropic effects of thiazolidinediones: taking a look beyond antidiabetic activity.PPARgamma and Apoptosis in Cancer.Clinical Use of PPARgamma Ligands in Cancer.New agents in the treatment for malignancies of the salivary and thyroid glands.PPARgamma activation induces autophagy in breast cancer cells.Targeting anoikis resistance in prostate cancer metastasis.New molecular targeted therapy and redifferentiation therapy for radioiodine-refractory advanced papillary thyroid carcinoma: literature review Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.Expression profiling reveals a distinct transcription signature in follicular thyroid carcinomas with a PAX8-PPAR(gamma) fusion oncogene.Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.Peroxisome proliferator-activated receptor gamma overexpression and knockdown: impact on human B cell lymphoma proliferation and survival.PPAR-gamma expression in pituitary tumours and the functional activity of the glitazones: evidence that any anti-proliferative effect of the glitazones is independent of the PPAR-gamma receptor.Inhibition of peroxisome proliferator-activated receptor gamma activity in esophageal carcinoma cells results in a drastic decrease of invasive properties.MK886 inhibits the pioglitazone-induced anti-invasion of MDA-MB-231 cells is associated with PPARα/γ, FGF4 and 5LOX.Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours.The Role of the PAX8/PPARgamma Fusion Oncogene in Thyroid Cancer.Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells.Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer for Reapplication of I-131 Therapy.Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation.[Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].Association between peroxisome proliferator-activated receptor-γ gene polymorphism (Pro12Ala) and Helicobacter pylori infection in gastric carcinogenesis.Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas

P2860

Q27011352-32369892-69B6-452F-B85C-69A7D5E1F9FA Q28209267-7D6109A0-4609-4C03-81F0-5423B2DF7680 Q28244806-AAA31BE3-61BA-435D-979B-0C8458C88193 Q33288486-2B632D64-4876-4DDF-A3FF-0A6FA2E9B378 Q33496190-7ECCCDA4-3B42-437F-9F26-0CAE3CB0E383 Q33688828-FB85851F-6E6B-4F4F-949E-9EE1EA7A8BF3 Q33704599-F8BECBF6-21DA-46E3-98A0-F6D58AEE2FA2 Q34417994-11C12E2C-6649-4D3E-902C-EB4C218657A7 Q34990890-4CBB4F8A-5A47-4DCD-99D7-0441290DDF38 Q35583906-6F45F0CA-F4DC-434B-B5D0-9D41018345E3 Q35584840-7EF7E738-D9A8-400B-A17E-169F2E5DA4F4 Q35608757-85C31A7A-5A8A-41D3-A2EC-96748E8DCCBC Q35749248-3C4B1758-28C9-4378-A9F1-1FCE06D8C385 Q35770556-2723B566-A0CA-4E9A-BEF5-DF92155F1156 Q35842601-BCA8276B-1F95-40E5-89F9-0A4912F39A67 Q36068458-FEFE488D-BD41-4AC4-93CC-2DE35211BBA3 Q36742811-314529CC-882B-4B2D-A706-C98F9F97C20C Q37021288-5BCAE280-9C25-4F61-8185-A01DF27864E7 Q37137859-49AF293E-24C9-4DBE-94B8-67EE9A02D18D Q37366778-7DBDE962-8DB7-47E2-A44A-570761856412 Q37691830-38A7FC1A-FA1A-4BAA-84DA-1EB09BE03BE3 Q38074169-59D270F2-B43A-4DC1-8474-273239D64A6A Q38324581-09D97703-8E1F-444C-B4D0-10C419174963 Q38332874-D933FBBD-587C-4BEE-87CA-C8936E86E39B Q39698351-6A183126-3FF8-4C27-9A95-4161EA7ED047 Q39914845-440E4BEF-0A4E-4420-9842-7949893943C8 Q40242074-EDAE370B-E8AF-4C5E-A23C-586B5531A478 Q40262195-ED148777-CC0F-414E-9B69-3E16A82ECDCD Q41639652-96B334AF-12C3-46B1-82B7-08D621061DEA Q41894503-7E8696E5-0AEE-4377-BFA1-F2403060FA08 Q42023771-5B002676-F126-4500-A121-3D1131CC6CCF Q42443356-DF2B4C12-1830-4CE3-B843-746E6F6EFE17 Q46073511-CB11812B-D4DE-43A7-9AE6-00362E460D09 Q46981242-C746F7C4-AC46-4C37-8F80-2D3590DD8873 Q46985000-81C38579-E3D6-4617-8124-2CD42661DAEC Q53297929-B635DED4-2C88-42A4-8C21-995F683093D5 Q57591206-7441EA3D-E1EB-4104-810C-0596A274D1B2

P2860

Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth.

http://www.wikidata.org/entity/Q40699776

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

2002年论文

@zh

2002年论文

@zh-cn

name

Inhibitory effects of peroxiso ...... thyroid carcinoma cell growth.

@en

type

label

Inhibitory effects of peroxiso ...... thyroid carcinoma cell growth.

@en

prefLabel

Inhibitory effects of peroxiso ...... thyroid carcinoma cell growth.

@en

P1433

Q40699776-9A689AF2-724F-4AA4-AFBF-E133A9D514F1

P1476

Q40699776-B05E183E-64FA-4C7E-B72A-B4133BD6E52B

P2093

Q40699776-1B0C4270-F320-45AA-B309-413C1A2FE5BB

Q40699776-268562B3-358C-4BA0-9DC0-7BA544F2768D

Q40699776-3B217CF1-955A-4B5C-AA7B-B1B83EBD12B5

Q40699776-4E65ABA1-7A7D-4764-A5B5-7AC14706D26A

Q40699776-74DEBFE1-774E-4B23-AFAF-E6E1E0550CA0

Q40699776-7892657A-080F-44EF-941E-5A806B275FDC

Q40699776-A32E7F65-FFF4-495B-B2A2-9CEFDBF8A17F

Q40699776-C21B8F0F-4EAC-4DB7-B4CA-689B27A3BFB8

Q40699776-F54E3F23-96B7-448F-80B1-DD482CF8599E

P304

Q40699776-05B25FDB-F38D-4533-AE52-58E25D9632F0

P31

Q40699776-EE702545-AE31-44BF-B454-C10E32C8C39F

P356

Q40699776-2592D709-B3C6-460B-A4B9-1BA34179616A

P407

Q40699776-0E02F465-F05F-41A4-92A6-6285EC92EE9A

P433

Q40699776-4AC9C87C-FC74-4273-B0DA-4A8B3FD3518A

P478

Q40699776-D135725E-AA7C-4800-BD81-E5EF5171E7C0

P50

Q40699776-DEC62D6C-5A2D-4BF4-8542-0530C934A025

P577

Q40699776-F1903FBD-8F4A-43E9-990C-8ADE759E7BD0

P5875

Q40699776-B04E6CAF-E41B-464D-B1E7-FF2720EAE08A

P698

Q40699776-9A55BFB4-A9DA-4512-B400-12555E0AB000

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Inhibitory effects of peroxiso ...... thyroid carcinoma cell growth.

@en

P2093

Carmen Monaco

http://www.w3.org/2001/XMLSchema#string

Ilaria Le Pera

http://www.w3.org/2001/XMLSchema#string

Irene Sama'

http://www.w3.org/2001/XMLSchema#string

Lorenzo Chiariotti

http://www.w3.org/2001/XMLSchema#string

Maria Luisa Martelli

http://www.w3.org/2001/XMLSchema#string

Massimo Santoro

http://www.w3.org/2001/XMLSchema#string

Rodolfo Iuliano

http://www.w3.org/2001/XMLSchema#string

Simona Cammarota

http://www.w3.org/2001/XMLSchema#string

Todd Kroll

http://www.w3.org/2001/XMLSchema#string

P304

4728-4735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2001-012054

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P50

P577

2002-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11094396

http://www.w3.org/2001/XMLSchema#string

P698

12364466

http://www.w3.org/2001/XMLSchema#string